State of Society and MS Research
Dr. John Richert is the former Executive Vice President for Research and Clinical Programs at the Society. He headed the world’s leading MS biomedical, clinical and healthcare policy research initiatives and oversaw the Society’s extensive professional information and education programs. Dr. Richert was with the Society from 2005-2010, and under his leadership, the Society launched bold new strategic efforts to increase its role as a driving force in MS research.
Dr. Richard Rudick is both Director of the Mellen Center for MS Treatment and Research and Vice Chairman of Research and Development at the Neurological Institute at the Cleveland Clinic. Dr. Rudick is also Chair of the Society’s Research Programs Advisory Committee. He has played key roles in several pivotal MS clinical trials, continues studies on immunologic changes in MS patients, and has led development of new clinical and imaging measures for MS trials. In addition, he continues to see MS patients at the Mellen Center.